ACC-2017 Pregnancy - CHD: Difference between revisions

Jump to navigation Jump to search
Line 15: Line 15:


|-  
|-  
| I || No detectable increase in maternal mortality and no/mild increase in morbidity risk || Uncomplicated small/mild pulmonary stenosis, PDA, mitral valve prolapse;  
| '''I''' || No detectable increase in maternal mortality and no/mild increase in morbidity risk || Uncomplicated small/mild pulmonary stenosis, PDA, mitral valve prolapse;  
Successfully repaired simple lesions (ASD, VSD, PDA, anomalous pulmonary venous drainage); Atrial or ventricular ectopic beats, isolated
Successfully repaired simple lesions (ASD, VSD, PDA, anomalous pulmonary venous drainage); Atrial or ventricular ectopic beats, isolated
|-  
|-  
| II || Small increase in maternal mortality and moderate increase in morbidity risk || If otherwise well and uncomplicated: Unoperated ASD, VSD;  
| '''II''' || Small increase in maternal mortality and moderate increase in morbidity risk || If otherwise well and uncomplicated: Unoperated ASD, VSD;  
Repaired TOF;  
Repaired TOF;  


Most arrhythmias
Most arrhythmias
|-  
|-  
| II–III || Moderate increase in maternal mortality morbidity risk || Mild LV impairment;  
| '''II–III''' || Moderate increase in maternal mortality morbidity risk || Mild LV impairment;  
Hypertrophic cardiomyopathy;   
Hypertrophic cardiomyopathy;   


Line 34: Line 34:
Repaired coarctation
Repaired coarctation
|-  
|-  
| IV || Extremely high maternal mortality or severe morbidity risk. Pregnancy is contraindicated. In the event of pregnancy, termination should be discussed. If pregnancy continues, care should follow class III recommendations. || Pulmonary arterial hypertension (of any cause);  
| '''IV''' || Extremely high maternal mortality or severe morbidity risk. Pregnancy is contraindicated. In the event of pregnancy, termination should be discussed. If pregnancy continues, care should follow class III recommendations. || Pulmonary arterial hypertension (of any cause);  
Severe systemic ventricular dysfunction (LV ejection fraction <30%, NYHA class III-IV);  
Severe systemic ventricular dysfunction (LV ejection fraction <30%, NYHA class III-IV);  



Revision as of 16:36, 2 November 2017


Template:Pregnancy -CHD - 2017 Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Arzu Kalayci, M.D. [2]

Management of Pregnancy in Patients With Complex Congenital heart Disease

Modified Who Classification of Maternal Cardiovascular Risk

Who Pregnancy Risk Category Risk Description Maternal Risk Factors
I No detectable increase in maternal mortality and no/mild increase in morbidity risk Uncomplicated small/mild pulmonary stenosis, PDA, mitral valve prolapse;

Successfully repaired simple lesions (ASD, VSD, PDA, anomalous pulmonary venous drainage); Atrial or ventricular ectopic beats, isolated

II Small increase in maternal mortality and moderate increase in morbidity risk If otherwise well and uncomplicated: Unoperated ASD, VSD;

Repaired TOF;

Most arrhythmias

II–III Moderate increase in maternal mortality morbidity risk Mild LV impairment;

Hypertrophic cardiomyopathy;

Native or tissue valvular disease (not considered risk category I or IV);

Marfan syndrome without aortic dilation;

Aortic dilation <45 mm in bicuspid aortic valve aortopathy;

Repaired coarctation

IV Extremely high maternal mortality or severe morbidity risk. Pregnancy is contraindicated. In the event of pregnancy, termination should be discussed. If pregnancy continues, care should follow class III recommendations. Pulmonary arterial hypertension (of any cause);

Severe systemic ventricular dysfunction (LV ejection fraction <30%, NYHA class III-IV);

Previous peripartum cardiomyopathy with any residual impairment of LV function;

Severe mitral stenosis, severe symptomatic aortic stenosis;

Aortic dilation >45 mm in Marfan syndrome;

Aortic dilation >50 mm in bicuspid aortic valve aortopathy;

Native severe coarctation

AS indicates aortic stenosis; ASD, atrial septal defect; CHD, congenital heart disease; LV, left ventricular; NYHA, New York Heart Association; PDA, patent ductus arteriosus; RV, right ventricle; TOF, tetralogy of Fallot; VSD, ventricular septal defect; and WHO, World Health Organisation.